44 : 577585 Taglialatela G, Navarra D, Olivi A, Ramacci MT, Werrbach-Perez K, Perez-Polo JR et al
Consensus statement by the american association of clinical endocrinologists and american college of endocrinology on the comprehensive type 2 diabetes management algorithm - 2018 executive summary
Tirzepatide is not recommended during pregnancy, particularly when used for weight management, and can reduce the effectiveness of oral contraceptives
Keep all related medical records, prescription bottles, pharmacy receipts, and any communications you have had with your doctor about the medication
The goal of this review is to highlight the cardioprotective role of IF by providing a comprehensive overview of the effects of IF on cellular dynamics, lipid profile, and adipose tissue concentration